1 |
Chubak J, Boudreau DM, Fishman PA, Elmore JG. Cost of breast-related care in the year following false positive screening mammograms. Med Care 2010;48(9):815-820.
DOI
|
2 |
Anhang Price R, Zapka J, Edwards H, Taplin SH. Organizational factors and the cancer screening process. J Natl Cancer Inst Monogr 2010;2010(40):38-57.
DOI
|
3 |
Young GP. Population-based screening for colorectal cancer: Australian research and implementation. J Gastroenterol Hepatol 2009;24 Suppl 3:S33-S42.
DOI
|
4 |
Leavell HR, Clark EG. Preventive medicine for the doctor in his community: an epidemiologic approach. 3rd ed. New York: McGraw-Hill; 1960, p. 20-21.
|
5 |
Clark EG. Natural history of syphilis and levels of prevention. Br J Vener Dis 1954;30(4):191-197.
|
6 |
Mahon SM. Principles of cancer prevention and early detection. Clin J Oncol Nurs 2000;4(4):169-176.
|
7 |
Bae JM. The author reply: a comment on "quaternary prevention in public health". J Prev Med Public Health 2016;49(2):141.
DOI
|
8 |
Jamoulle M, Roland M. Quaternary prevention; 1995 [cited 2016 Feb 24]. Available from: http://www.ph3c.org/PH3C/docs/27/000103/0000261.pdf.
|
9 |
Jamoulle M. First do not harm. J Midlife Health 2015;6(2):51-52.
|
10 |
Widmer D, Herzig L, Jamoulle M. Quaternary prevention: is acting always justified in family medicine? Rev Med Suisse 2014;10(430):1052-1056 (French).
|
11 |
Sadegh-Zadeh K. Handbook of analytic philosophy of medicine. 2nd ed. Dordrecht: Springer; 2015, p. 37-46.
|
12 |
Usherwood TP. Responses to illness--implications for the clinician. J R Soc Med 1990;83(4):205-207.
DOI
|
13 |
Green AR, Carrillo JE, Betancourt JR. Why the disease-based model of medicine fails our patients. West J Med 2002;176(2): 141-143.
|
14 |
Wakefield JC. The concept of mental disorder: diagnostic implications of the harmful dysfunction analysis. World Psychiatry 2007;6(3):149-156.
|
15 |
van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998;51(5):367-375.
DOI
|
16 |
Sinnott C, Mc Hugh S, Browne J, Bradley C. GPs' perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open 2013;3(9):e003610.
DOI
|
17 |
Kiviniemi MT, Hay JL, James AS, Lipkus IM, Meissner HI, Stefanek M, et al. Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer Epidemiol Biomarkers Prev 2009;18(11):3133-3137.
DOI
|
18 |
Boone E, Lewis L, Karp M. Discontent and confusion: primary care providers' opinions and understanding of current cervical cancer screening recommendations. J Womens Health (Larchmt) 2016;25(3):255-262.
DOI
|
19 |
Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2009;59(1):27-41.
DOI
|
20 |
Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples. Inhal Toxicol 2014;26(13):811-828.
DOI
|
21 |
Plsek PE, Greenhalgh T. Complexity science: the challenge of complexity in health care. BMJ 2001;323(7313):625-628.
DOI
|
22 |
Kramer BS, Croswell JM. Cancer screening: the clash of science and intuition. Annu Rev Med 2009;60:125-137.
DOI
|
23 |
Müller-Engelmann M, Keller H, Donner-Banzhoff N, Krones T. Shared decision making in medicine: the influence of situational treatment factors. Patient Educ Couns 2011;82(2):240-246.
DOI
|
24 |
Zapka J, Taplin SH, Price RA, Cranos C, Yabroff R. Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care. J Natl Cancer Inst Monogr 2010;2010(40):58-71.
DOI
|
25 |
Torke AM, Schwartz PH, Holtz LR, Montz K, Sachs GA. Older adults and forgoing cancer screening: "I think it would be strange". JAMA Intern Med 2013;173(7):526-531.
DOI
|
26 |
Gomes LF, Gusso G, Jamoulle M. Teaching and learning quaternary prevention. Rev Bras Med Fam Comunidade 2015;10 (35):1-14.
|
27 |
Levesque JF, Breton M, Senn N, Levesque P, Bergeron P, Roy DA. The interaction of public health and primary care: functional roles and organizational models that bridge individual and population perspectives. Public Health Rev 2013;35(1):1-27.
|
28 |
Bae JM. Development and application of patient decision aids. Epidemiol Health 2015;37:e2015018.
DOI
|
29 |
Sieber WJ, Kaplan RM. Informed adherence: the need for shared medical decision making. Control Clin Trials 2000;21(5 Suppl):233S-240S.
DOI
|
30 |
Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med 2014;371(19): 1765-1767.
DOI
|
31 |
Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med 2013;369(14):1336-1343.
DOI
|
32 |
Dean E. Physical therapy in the 21st century (Part I): toward practice informed by epidemiology and the crisis of lifestyle conditions. Physiother Theory Pract 2009;25(5-6):330-353.
DOI
|
33 |
Health Quality Ontario. Continuity of care to optimize chronic disease management in the community setting: an evidence-based analysis. Ont Health Technol Assess Ser 2013;13(6):1-41.
|
34 |
Hakkarainen KM, Gyllensten H, JOnsson AK, Andersson Sundell K, Petzold M, Hagg S. Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults. Br J Clin Pharmacol 2014; 78(1):170-183.
DOI
|
35 |
Harris M. The role of primary health care in preventing the onset of chronic disease, with a particular focus on the lifestyle risk factors of obesity, tobacco and alcohol; 2008 [cited 2016 Oct 20]. Available from: http://www.preventativehealth.org.au/internet/preventativehealth/publishing.nsf/Content/0FBE203C1C547A82CA257529000231BF/$File/commpaper-primary-hlth-care-harris.pdf.
|
36 |
Dans LF, Silvestre MA, Dans AL. Trade-off between benefit and harm is crucial in health screening recommendations. Part I: general principles. J Clin Epidemiol 2011;64(3):231-239.
DOI
|
37 |
Wald NJ. Guidance on terminology. J Med Screen 2006;13(1):53.
DOI
|
38 |
Saquib N, Saquib J, Ioannidis JP. Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials. Int J Epidemiol 2015;44(1): 264-277.
DOI
|
39 |
Gigerenzer G. Full disclosure about cancer screening. BMJ 2016;352:h6967.
|
40 |
Khunger M, Kumar U, Roy HK, Tiwari AK. Dysplasia and cancer screening in 21st century. APMIS 2014;122(8):674-682.
DOI
|
41 |
Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 2014; 311(13):1327-1335.
DOI
|
42 |
Walter LC, Schonberg MA. Screening mammography in older women: a review. JAMA 2014;311(13):1336-1347.
DOI
|
43 |
Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007;146(7):516-526.
DOI
|
44 |
McCartney M. Margaret McCartney: cancer strategy should be led by evidence. BMJ 2015;350:h735.
DOI
|
45 |
Gates TJ. Screening for cancer: evaluating the evidence. Am Fam Physician 2001;63(3):513-522.
|
46 |
Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q 2005;83 (4):731-757.
DOI
|
47 |
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3(11):e442.
DOI
|
48 |
Barrett B, McKenna P. Communicating benefits and risks of screening for prostate, colon, and breast cancer. Fam Med 2011;43(4):248-253.
|
49 |
Onega T, Beaber EF, Sprague BL, Barlow WE, Haas JS, Tosteson AN, et al. Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer 2014;120(19):2955-2964.
DOI
|